176 related articles for article (PubMed ID: 33437205)
1. Fhit induces the reciprocal suppressions between Lin28/Let-7 and miR-17/92miR.
Chae HJ; Seo JB; Kim SH; Jeon YJ; Suh SS
Int J Med Sci; 2021; 18(3):706-714. PubMed ID: 33437205
[No Abstract] [Full Text] [Related]
2. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.
Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I
Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032
[TBL] [Abstract][Full Text] [Related]
3. Let-7 miRNA Precursors Co-express with LIN28B in Cervical Cells.
Zamora-Contreras AM; Alvarez-Salas LM
Microrna; 2018; 7(1):62-71. PubMed ID: 29336272
[TBL] [Abstract][Full Text] [Related]
4. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.
Mong EF; Akat KM; Canfield J; Lockhart J; VanWye J; Matar A; Tsibris JCM; Wu JK; Tuschl T; Totary-Jain H
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1321-1332. PubMed ID: 29724816
[TBL] [Abstract][Full Text] [Related]
5. miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer.
Zhou Y; Liang H; Liao Z; Wang Y; Hu X; Chen X; Xu L; Hu Z
Sci Rep; 2017 Feb; 7():42680. PubMed ID: 28218277
[TBL] [Abstract][Full Text] [Related]
6. LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer.
Sakurai M; Miki Y; Masuda M; Hata S; Shibahara Y; Hirakawa H; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):101-6. PubMed ID: 22081076
[TBL] [Abstract][Full Text] [Related]
7. Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva.
Agostini A; Brunetti M; Davidson B; Trope CG; Heim S; Panagopoulos I; Micci F
Oncotarget; 2016 Dec; 7(51):85058-85062. PubMed ID: 27835588
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Lin28B Promoted the Proliferation of Adenomyotic Smooth Muscle Cells of the Junctional Zone via Regulating Let-7a.
Lin SL; Duan H; Wang S; Li JJ
Reprod Sci; 2020 May; 27(5):1156-1163. PubMed ID: 32046465
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
10. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs.
Suh SS; Yoo JY; Cui R; Kaur B; Huebner K; Lee TK; Aqeilan RI; Croce CM
PLoS Genet; 2014 Oct; 10(10):e1004652. PubMed ID: 25340791
[TBL] [Abstract][Full Text] [Related]
11. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
12. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
[TBL] [Abstract][Full Text] [Related]
13. microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression.
Lin YX; Yu F; Gao N; Sheng JP; Qiu JZ; Hu BC
Cancer Biother Radiopharm; 2011 Jun; 26(3):365-72. PubMed ID: 21711110
[TBL] [Abstract][Full Text] [Related]
14. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
15. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
[TBL] [Abstract][Full Text] [Related]
16. FHIT: doubts are clear now.
Wali A
ScientificWorldJournal; 2010 Jun; 10():1142-51. PubMed ID: 20563537
[TBL] [Abstract][Full Text] [Related]
17. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.
Kiss DL; Waters CE; Ouda IM; Saldivar JC; Karras JR; Amin ZA; Mahrous S; Druck T; Bundschuh RA; Schoenberg DR; Huebner K
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):374-382. PubMed ID: 28093273
[TBL] [Abstract][Full Text] [Related]
18. Lin28 promotes transformation and is associated with advanced human malignancies.
Viswanathan SR; Powers JT; Einhorn W; Hoshida Y; Ng TL; Toffanin S; O'Sullivan M; Lu J; Phillips LA; Lockhart VL; Shah SP; Tanwar PS; Mermel CH; Beroukhim R; Azam M; Teixeira J; Meyerson M; Hughes TP; Llovet JM; Radich J; Mullighan CG; Golub TR; Sorensen PH; Daley GQ
Nat Genet; 2009 Jul; 41(7):843-8. PubMed ID: 19483683
[TBL] [Abstract][Full Text] [Related]
19. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
20. The FHIT gene product: tumor suppressor and genome "caretaker".
Waters CE; Saldivar JC; Hosseini SA; Huebner K
Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
